0001209191-20-057368.txt : 20201106
0001209191-20-057368.hdr.sgml : 20201106
20201106191620
ACCESSION NUMBER: 0001209191-20-057368
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201105
FILED AS OF DATE: 20201106
DATE AS OF CHANGE: 20201106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SLACIK CHARLES P
CENTRAL INDEX KEY: 0001204660
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-10961
FILM NUMBER: 201295719
MAIL ADDRESS:
STREET 1: 250 S. KRAEMER BLVD
CITY: BREA
STATE: CA
ZIP: 92821
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUIDEL CORP /DE/
CENTRAL INDEX KEY: 0000353569
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 942573850
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8585521100
MAIL ADDRESS:
STREET 1: 9975 SUMMERS RIDGE ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/
DATE OF NAME CHANGE: 19910210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-11-05
0
0000353569
QUIDEL CORP /DE/
QDEL
0001204660
SLACIK CHARLES P
9975 SUMMERS RIDGE ROAD
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2020-11-05
4
M
0
4009
20.82
A
15224
D
Common Stock
2020-11-05
4
S
0
4009
282.4614
D
11215
D
Non-Qualified Stock Option
20.82
2020-11-05
4
M
0
4009
0.00
D
2016-05-05
2025-11-16
Common Stock
4009
0
D
The amount of securities beneficially owned following this transaction include a reduction of shares due to the prior gifting of 137 shares by the reporting person to a bona fide charitable organization.
The weighted average sale price for these transactions was $282.4614 per share, with a range of $282.11 to $282.60. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Robert J. Bujarski, attorney-in-fact for Charles P. Slacik
2020-11-06